Newsletter | April 11, 2025

04.11.25 -- Companies To Watch: Imunon

FEATURED ARTICLE

Companies To Watch: Imunon

Imunon aims to shake up the standard of care in the frontline treatment of advanced ovarian cancer.

INDUSTRY INSIGHTS

EU HTA – What Will It Take For Innovative Medicines To Succeed?

Discover how to navigate the EU HTAR's Joint Clinical Assessment process. Learn from industry experts about accelerating patient access to innovative medicines in Europe.

Where Precision Meets Personal Connection

Robert Lohayza, a Certified Mobile Research Nurses (CMRN), shares his experience and underscores the essential role of mobile clinicians in advancing global clinical research.

Innovation In Filtration

Filtration is essential in various applications that remove contaminants to ensure safety and efficiency. Explore how its simplicity and reliability make it indispensable across industries.

Nitrosamine Impurities Deadline: Are Your Products Compliant?

The FDA nitrosamine contamination guidance set a deadline of August 1, 2025, for all drug manufacturers and market authorization holders to comply fully with the NDSRI limits set.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.